Heather H Cheng

Summary

Affiliation: University of Washington
Country: USA

Publications

  1. doi Advanced clinical states in prostate cancer
    Heather H Cheng
    Division of Medical Oncology, Department of Medicine, University of Washington, Seattle, WA 98109, USA
    Urol Clin North Am 39:561-71. 2012
  2. pmc Improved disease markers suggest dual response in a patient with metastatic castration resistant prostate cancer and chronic lymphocytic leukemia following active cellular immunotherapy
    Heather H Cheng
    University of Washington, Seattle, USA
    J Hematol Oncol 8:51. 2015
  3. pmc Circulating microRNA profiling identifies a subset of metastatic prostate cancer patients with evidence of cancer-associated hypoxia
    Heather H Cheng
    Clinical Research Division, Fred Hutchinson Cancer Research Center, Seattle, Washington, USA
    PLoS ONE 8:e69239. 2013

Detail Information

Publications3

  1. doi Advanced clinical states in prostate cancer
    Heather H Cheng
    Division of Medical Oncology, Department of Medicine, University of Washington, Seattle, WA 98109, USA
    Urol Clin North Am 39:561-71. 2012
    ..The authors define the current disease states and discuss implications for prognosis and treatment decisions, as well as the limitations of existing classifications and emerging discoveries...
  2. pmc Improved disease markers suggest dual response in a patient with metastatic castration resistant prostate cancer and chronic lymphocytic leukemia following active cellular immunotherapy
    Heather H Cheng
    University of Washington, Seattle, USA
    J Hematol Oncol 8:51. 2015
    ..This case report suggests that treatment with sipuleucel-T can rarely lead to PSA decline, may have dual activity against both prostate cancer and CLL, and that these findings warrant further investigation. ..
  3. pmc Circulating microRNA profiling identifies a subset of metastatic prostate cancer patients with evidence of cancer-associated hypoxia
    Heather H Cheng
    Clinical Research Division, Fred Hutchinson Cancer Research Center, Seattle, Washington, USA
    PLoS ONE 8:e69239. 2013
    ....